BUSINESS WIRE; Monday, June 29, 1998
The first in a class of web-based applications, PromptChart creates, organizes and manages a longitudinal database of critical patient data and presents that information in disease specific clinical views for physicians to develop more effective treatment strategies.
HIV PromptChart is a web-based software tool that gives physicians easy access to critical information needed to develop effective treatment strategies. In the context of clinical care it provides a framework for discussion of the patient's ongoing therapeutic response and the management of complications.
Using HIV PromptChart can decrease the time required to review critical laboratory values by providing concise visual tools that track longitudinal changes in relevant markers, such as viral load and CD4. PromptChart provides patient-specific reminders and alerts based on physician treatment guidelines. These alerts span the continuum from prophylaxis treatment recommendations through reminders of routine test needs and vaccines.
Using HIV PromptChart can enhance regimen compliance by providing physicians with customized, patient specific summaries and drug calendars that clearly specify when and how patients should take prescribed medications.
"PromptChart tracks all the patient's CD4 count and HIV RNA data in an easy-to-read graphical format, coupled with a time-line of the patient's prior and current antiretroviral therapy," said Carol Kemper, M.D., Associate Medical Director, AIDS Health Services and Clinical Assistant Professor of Medicine at Stanford University. "With one quick glance, the patient's treatment history, nadir HIV RNA response to therapy, the rate and duration of that response, the occurrence of viral recrudescence during therapy, as well as any possible relationship to the occurrence of intercurrent illness, infection, or immunization is immediately available."
"PromptChart offers both the provider and the patient the ability to manage the cooperative care delivery process, improving communication and compliance with complex treatment strategies and protocols," said Peter A. Thompson, M.D. FACP, vice president and general manager of Chiron Informatics. "Chiron Informatics is leading the industry in computer-based decision support tools for developing and distributing clinical guidelines and protocols. PromptChart will ultimately serve as a web-based or browser-based graphical user interface for underlying platforms of executable code from other Chiron Informatics product lines or product classes."
PromptChart marks the first knowledge based, disease-specific, information management service from Chiron Informatics and will initially be released in the United States in the summer of 1998 with European releases planned in the spring of 1999. The software is organized into two modules -- the Visit Preparation Module, expected to be generally available by late summer and the Treatment Module, which is expected to be available in December 1998.
Chiron Informatics is developing state-of-the-art decision support, data mining technology and medical management consulting services that facilitate the implementation of comprehensive practice guidelines for health care delivery systems. Chiron Informatics leverages strong internal competencies in biomedical science, health services research, informatics, and data analytics.
Chiron Corporation is a science-driven, market-directed healthcare company that combines diagnostic, vaccine and therapeutic strategies for controlling disease. Chiron participates in three global markets: diagnostics including immunodiagnostics, critical care diagnostics, and new quantitative probe tests; pediatric and adult vaccines and therapeutics, with an emphasis on oncology and infectious disease. Chiron also has research programs underway in gene therapy and gene transfer, combinatorial chemistry, cardiovascular disease, critical care and medical informatics.
This news release contains forward-looking statements that involve risks and uncertainties, which might affect the initiation and completion of clinical trials and the launch of products. A full discussion of the companies' operations and financial condition, including factors that may affect their business and future prospects, is contained in documents the companies file with the SEC, such as form 10-Q and 10-K and 40F reports. These documents identify important factors that could cause the companies' actual performance to differ from current expectations, including the outcome of clinical trials, regulatory review, manufacturing capabilities and marketing effectiveness.
CONTACT: Chiron Informatics Joseph A. Condurso, 510/749-5250 or Chiron Diagnostics Judith Rossi, 508-660-4875
980629
BW980613
Copyright © 1998 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .